1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Autoimmune Drugs Revenue
1.4 Market by Type
1.4.1 Global Autoimmune Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Rheumatoid Arthritis (RA)
1.4.3 Multiple Sclerosis (MS)
1.4.4 Psoriasis
1.4.5 Inflammatory Bowel Disease (IBD)
1.4.6 Ankylosing Spondylitis (AS)
1.4.7 Systemic Lupus Erythematosus (SLE)
1.5 Market by Application
1.5.1 Global Autoimmune Drugs Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Homecare Settings
1.5.4 Specialty Clinics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Autoimmune Drugs Market Perspective (2015-2026)
2.2 Global Autoimmune Drugs Growth Trends by Regions
2.2.1 Autoimmune Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Autoimmune Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Autoimmune Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Autoimmune Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Autoimmune Drugs Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Autoimmune Drugs Players by Market Size
3.1.1 Global Top Autoimmune Drugs Players by Revenue (2015-2020)
3.1.2 Global Autoimmune Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Autoimmune Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Autoimmune Drugs Market Concentration Ratio
3.2.1 Global Autoimmune Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Autoimmune Drugs Revenue in 2019
3.3 Autoimmune Drugs Key Players Head office and Area Served
3.4 Key Players Autoimmune Drugs Product Solution and Service
3.5 Date of Enter into Autoimmune Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Autoimmune Drugs Historic Market Size by Type (2015-2020)
4.2 Global Autoimmune Drugs Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Autoimmune Drugs Market Size by Application (2015-2020)
5.2 Global Autoimmune Drugs Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Autoimmune Drugs Market Size (2015-2020)
6.2 Autoimmune Drugs Key Players in North America (2019-2020)
6.3 North America Autoimmune Drugs Market Size by Type (2015-2020)
6.4 North America Autoimmune Drugs Market Size by Application (2015-2020)
7 Europe
7.1 Europe Autoimmune Drugs Market Size (2015-2020)
7.2 Autoimmune Drugs Key Players in Europe (2019-2020)
7.3 Europe Autoimmune Drugs Market Size by Type (2015-2020)
7.4 Europe Autoimmune Drugs Market Size by Application (2015-2020)
8 China
8.1 China Autoimmune Drugs Market Size (2015-2020)
8.2 Autoimmune Drugs Key Players in China (2019-2020)
8.3 China Autoimmune Drugs Market Size by Type (2015-2020)
8.4 China Autoimmune Drugs Market Size by Application (2015-2020)
9 Japan
9.1 Japan Autoimmune Drugs Market Size (2015-2020)
9.2 Autoimmune Drugs Key Players in Japan (2019-2020)
9.3 Japan Autoimmune Drugs Market Size by Type (2015-2020)
9.4 Japan Autoimmune Drugs Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Autoimmune Drugs Market Size (2015-2020)
10.2 Autoimmune Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Autoimmune Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Autoimmune Drugs Market Size by Application (2015-2020)
11 India
11.1 India Autoimmune Drugs Market Size (2015-2020)
11.2 Autoimmune Drugs Key Players in India (2019-2020)
11.3 India Autoimmune Drugs Market Size by Type (2015-2020)
11.4 India Autoimmune Drugs Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Autoimmune Drugs Market Size (2015-2020)
12.2 Autoimmune Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Autoimmune Drugs Market Size by Type (2015-2020)
12.4 Central & South America Autoimmune Drugs Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Eli Lilly
13.1.1 Eli Lilly Company Details
13.1.2 Eli Lilly Business Overview
13.1.3 Eli Lilly Autoimmune Drugs Introduction
13.1.4 Eli Lilly Revenue in Autoimmune Drugs Business (2015-2020))
13.1.5 Eli Lilly Recent Development
13.2 GSK
13.2.1 GSK Company Details
13.2.2 GSK Business Overview
13.2.3 GSK Autoimmune Drugs Introduction
13.2.4 GSK Revenue in Autoimmune Drugs Business (2015-2020)
13.2.5 GSK Recent Development
13.3 AbbVie
13.3.1 AbbVie Company Details
13.3.2 AbbVie Business Overview
13.3.3 AbbVie Autoimmune Drugs Introduction
13.3.4 AbbVie Revenue in Autoimmune Drugs Business (2015-2020)
13.3.5 AbbVie Recent Development
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Details
13.4.2 Johnson & Johnson Business Overview
13.4.3 Johnson & Johnson Autoimmune Drugs Introduction
13.4.4 Johnson & Johnson Revenue in Autoimmune Drugs Business (2015-2020)
13.4.5 Johnson & Johnson Recent Development
13.5 Biogen
13.5.1 Biogen Company Details
13.5.2 Biogen Business Overview
13.5.3 Biogen Autoimmune Drugs Introduction
13.5.4 Biogen Revenue in Autoimmune Drugs Business (2015-2020)
13.5.5 Biogen Recent Development
13.6 Amgen
13.6.1 Amgen Company Details
13.6.2 Amgen Business Overview
13.6.3 Amgen Autoimmune Drugs Introduction
13.6.4 Amgen Revenue in Autoimmune Drugs Business (2015-2020)
13.6.5 Amgen Recent Development
13.7 Pfizer
13.7.1 Pfizer Company Details
13.7.2 Pfizer Business Overview
13.7.3 Pfizer Autoimmune Drugs Introduction
13.7.4 Pfizer Revenue in Autoimmune Drugs Business (2015-2020)
13.7.5 Pfizer Recent Development
13.8 Roche
13.8.1 Roche Company Details
13.8.2 Roche Business Overview
13.8.3 Roche Autoimmune Drugs Introduction
13.8.4 Roche Revenue in Autoimmune Drugs Business (2015-2020)
13.8.5 Roche Recent Development
13.9 Baxter
13.9.1 Baxter Company Details
13.9.2 Baxter Business Overview
13.9.3 Baxter Autoimmune Drugs Introduction
13.9.4 Baxter Revenue in Autoimmune Drugs Business (2015-2020)
13.9.5 Baxter Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
【掲載企業】
Eli Lilly、GSK、AbbVie、Johnson & Johnson、Biogen、Amgen、Pfizer、Roche、Baxter
【免責事項】
https://www.globalresearch.jp/disclaimer